Armistice Capital, LLC Pfizer Inc Transaction History

Armistice Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $75.7 Million - $87.6 Million	2,096,000 New	2,096,000 $76.9 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $3.5 Million - $4.27 Million	80,000 Added 17.54%	536,000 $23.5 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $21.2 Million - $25.2 Million	456,000 New	456,000 $23.9 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $10.3 Million - $15.3 Million	-250,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $30.4 Million - $39 Million	-774,000 Reduced 75.59%	250,000 $10.8 Million
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $6.32 Million - $7.16 Million	-176,000 Reduced 14.67%	1,024,000 $40.1 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $40.2 Million - $45.3 Million	1,200,000 New	1,200,000 $43.5 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $20.4 Million - $24.8 Million	-678,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $18.3 Million - $26.2 Million	678,000 New	678,000 $22.1 Million

3,218

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Armistice Capital, LLC with notifications on news.